Article
Recapitulation of Clinical Individual Susceptibility to Drug-Induced QT Prolongation in Healthy Subjects Using iPSC-Derived Cardiomyocytes.
Stem cell reports - 14 Feb 2017
Shinozawa Tadahiro, Nakamura Koki, Shoji Masanobu, Morita Maya, Kimura Maya, Furukawa Hatsue, Ueda Hiroki, Shiramoto Masanari, Matsuguma Kyoko, Kaji Yoshikazu, Ikushima Ippei, Yono Makoto, Liou Shyh-Yuh, Nagai Hirofumi, Nakanishi Atsushi, Yamamoto Keiji, Izumo Seigo
Abstract excerpt
To predict drug-induced serious adverse events (SAE) in clinical trials, a model using a panel of cells derived from human induced pluripotent stem cells (hiPSCs) of individuals with different susceptibilities could facilitate major advancements in translational research in terms of safety and pharmaco-economics. However, it is unclear whether hiPSC-derived cells can recapitulate interindividual differences in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
